In this video Dr. Adnan Siddiqui and Dr. Matthew McPheeters placed, during the River Trial, The River Stent ™ in a patient with right transverse sinus stenosisNarrowing of the transverse sinus of the brain. It is a likely source of intracranial hypertension seen in patients with IIH. Click the term to read more and IIH. The River Stent™ is now an FDA-approved medical device for the treatment of severe, refractory IdiopathicThe term idiopathic is used when there is no detectable reason for something. Click the term to read more Intracranial Hypertension.
The patient was 28 year-old at the time of the procedure and was diagnosed with IIH with a criteria of papilledemaSwelling of the optic nerve that carries visual signals from the eye to the brain. Click the term to read more and an opening pressure of 33 mm H₂0 and treated with acetazolamideMedication used to treat glaucoma, epilepsy, altitude sickness, periodic paralysis, idiopathic intracranial hypertension, urine alkalinization, and heart failure. Click the term to read more. Upon diagnostic venography, the patient was found to have a significant stenosis of her right transverse venous sinusA left and right channel that drains deoxygenated blood from the back of the head into systemic circulation. Click the term to read more measuring 11 mm Hg.
The procedure was performed under anesthesia and her right common femoral vein was accessed using an 8 Fr sheath.
Watch the full video to watch the placement of The River Stent™.
